Progyny gains as White House reportedly eyeing proposal to make IVF more accessible

2025-10-16 13:49:03 ET

More on Progyny

• Progyny's Strong Fundamentals And Global Growth: Why I Choose To Buy
• Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript
• Progyny raises full-year 2025 revenue guidance to $1.27B as member engagement and product expansion accelerate
• Progyny Non-GAAP EPS of $0.48 beats by $0.05, revenue of $332.87M beats by $12.75M
• Seeking Alpha’s Quant Rating on Progyny

Read the full article on Seeking Alpha

For further details see: